INTERNATIONAL FLAVORS & FRAGRANCES INC IFF

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

Last close 94.15 2026-10-23
Market cap $24.02B 2026-06-30 share count
52-week range 61.30 - 94.58

Valuation FY2025 figures against the last close

P/S2.2x
P/E—
P/FCF93.8x
EV/EBITDA50.7x
Dividend yield1.7%
Diluted EPS-1.41

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $10.89B$11.48B$11.48B$12.44B$11.66B$5.08B$5.14B$3.98B$3.40B$3.12B
Cost of revenue $6.95B$7.36B$7.80B$8.29B$7.92B$3.00B$3.03B$2.29B$1.93B$1.72B
Gross profit $3.94B$4.12B$3.68B$4.15B$3.73B$2.09B$2.11B$1.68B$1.47B$1.40B
R&D $694.0M$671.0M$636.0M$603.0M$629.0M$357.0M$346.0M$311.6M$295.5M$258.9M
SG&A $1.83B$2.00B$1.79B$1.77B$1.75B$949.0M$876.0M$707.5M$570.1M$572.5M
Operating income -$382.0M$766.0M-$2.11B-$1.33B$585.0M$566.0M$665.0M$583.9M$552.6M$553.0M
Interest expense $229.0M$305.0M$380.0M$336.0M$289.0M$132.0M$138.0M$132.6M$65.4M$53.0M
Pre-tax income -$412.0M$308.0M-$2.52B-$1.62B$354.0M$441.0M$557.0M$447.8M$537.0M$523.7M
Income tax $53.0M$41.0M$69.0M$239.0M$75.0M$74.0M$97.0M$108.0M$241.4M$118.7M
Net income -$359.0M$267.0M-$2.59B-$1.86B$279.0M$367.0M$460.0M$339.8M$295.7M$405.0M
EPS, basic -1.411.04-10.14-7.321.113.254.053.813.735.07
EPS, diluted -1.411.04-10.14-7.321.103.214.003.793.725.05
Shares, diluted (wtd. avg.) 256.0M256.0M255.0M255.0M243.0M114.0M113.0M88.1M79.4M80.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $590.0M$469.0M$703.0M$483.0M$711.0M$660.0M$624.0M$649.0M$368.0M$324.0M
Receivables $1.73B$1.62B$1.73B$1.82B$1.91B$929.3M$60.8M$63.5M——
Inventory $2.25B$2.13B$2.48B$3.15B$2.52B$1.13B$1.12B$1.08B$649.4M$592.0M
Total current assets $5.59B$7.97B$6.29B$7.43B$6.99B$3.06B$2.94B$2.94B$1.90B$1.61B
Property, plant and equipment $4.03B$3.74B$4.24B$4.20B$4.37B$1.46B$1.39B$1.24B$880.6M$775.7M
Goodwill $8.27B$9.07B$10.63B$13.37B$16.43B$5.59B$5.50B$5.38B$1.16B$1.00B
Other intangibles $6.04B$6.45B$8.36B$9.08B$10.51B$2.73B$2.85B$3.04B$415.8M$365.8M
Total assets $25.54B$28.72B$30.98B$35.52B$39.66B$13.55B$13.29B$12.89B$4.60B$4.02B
Accounts payable $1.29B$1.28B$1.38B$1.42B$1.53B$556.0M$510.4M$471.4M$338.2M$274.8M
Short-term debt $1.25B$1.41B$885.0M$597.0M$632.0M$634.0M$385.0M$48.6M$7.0M$258.5M
Total current liabilities $3.93B$4.35B$3.76B$3.73B$3.63B$1.90B$1.55B$1.13B$768.8M$898.3M
Long-term debt $4.74B$7.56B$9.19B$10.37B$10.77B$3.78B$4.00B$4.50B$1.63B$1.07B
Retained earnings -$3.42B-$2.65B-$2.44B$955.0M$3.64B$4.16B$4.12B$3.96B$3.87B$3.82B
Total equity $14.15B$13.83B$14.58B$17.65B$21.12B$6.32B$6.23B$6.04B$1.69B$1.63B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $850.0M$1.07B$1.46B$397.0M$1.44B$714.0M$699.0M$437.6M$390.8M$550.1M
Depreciation and amortisation $962.0M$1.01B$1.14B$1.18B$1.16B$325.0M$323.0M$173.8M$118.0M$102.5M
Stock-based compensation $88.0M$77.0M$65.0M$49.0M$54.0M$36.0M$34.0M$29.4M$26.6M$24.6M
Capital expenditure $594.0M$463.0M$503.0M$504.0M$393.0M$192.0M$236.0M$170.1M$129.0M$126.4M
Investing cash flow $2.27B$326.0M$558.0M$745.0M-$18.0M-$187.0M-$226.0M-$5.01B-$299.9M-$355.5M
Financing cash flow -$3.09B-$1.61B-$1.85B-$1.23B-$1.30B-$512.0M-$505.0M$4.87B-$42.6M-$34.4M
Dividends paid $409.0M$514.0M$826.0M$810.0M$667.0M$323.0M$314.0M$230.2M$206.1M$184.9M
Buybacks $38.0M$0$0——$0$0$15.5M$58.1M$127.4M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000051253-26-000006.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B 15B Revenue, FY2016: 3.1B Gross profit, FY2016: 1.4B Net income, FY2016: 405M Revenue, FY2017: 3.4B Gross profit, FY2017: 1.5B Net income, FY2017: 295.7M Revenue, FY2018: 4B Gross profit, FY2018: 1.7B Net income, FY2018: 339.8M Revenue, FY2019: 5.1B Gross profit, FY2019: 2.1B Net income, FY2019: 460M Revenue, FY2020: 5.1B Gross profit, FY2020: 2.1B Net income, FY2020: 367M Revenue, FY2021: 11.7B Gross profit, FY2021: 3.7B Net income, FY2021: 279M Revenue, FY2022: 12.4B Gross profit, FY2022: 4.2B Net income, FY2022: -1.9B Revenue, FY2023: 11.5B Gross profit, FY2023: 3.7B Net income, FY2023: -2.6B Revenue, FY2024: 11.5B Gross profit, FY2024: 4.1B Net income, FY2024: 267M Revenue, FY2025: 10.9B Gross profit, FY2025: 3.9B Net income, FY2025: -359M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $3.12B $3.40B $3.98B $5.14B $5.08B $11.66B $12.44B $11.48B $11.48B $10.89B
Gross profit $1.40B $1.47B $1.68B $2.11B $2.09B $3.73B $4.15B $3.68B $4.12B $3.94B
Net income $405.0M $295.7M $339.8M $460.0M $367.0M $279.0M -$1.86B -$2.59B $267.0M -$359.0M

Recent filings and events

  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • New debt or obligation The company has taken on debt or a comparable obligation. Item 2.03
  • Material agreement signed Item 1.01
  • Other event Item 8.01
  • Results announced Item 2.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Results announced Item 2.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%
GEVO Gevo, Inc. $286.8M — 849.3%